| 000 | 01747 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517024118.0 | ||
| 264 | 0 | _c20160324 | |
| 008 | 201603s 0 0 eng d | ||
| 022 | _a1398-9995 | ||
| 024 | 7 |
_a10.1111/all.12620 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAlvarez-Cuesta, E | |
| 245 | 0 | 0 |
_aDelving into cornerstones of hypersensitivity to antineoplastic and biological agents: value of diagnostic tools prior to desensitization. _h[electronic resource] |
| 260 |
_bAllergy _cJul 2015 |
||
| 300 |
_a784-94 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAllergens _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aBiological Factors _xadverse effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aDesensitization, Immunologic |
| 650 | 0 | 4 |
_aDrug Hypersensitivity _xdiagnosis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin E _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOrganoplatinum Compounds _xadverse effects |
| 650 | 0 | 4 | _aOxaliplatin |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aSkin Tests |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aMadrigal-Burgaleta, R | |
| 700 | 1 | _aAngel-Pereira, D | |
| 700 | 1 | _aUreña-Tavera, A | |
| 700 | 1 | _aZamora-Verduga, M | |
| 700 | 1 | _aLopez-Gonzalez, P | |
| 700 | 1 | _aBerges-Gimeno, M P | |
| 773 | 0 |
_tAllergy _gvol. 70 _gno. 7 _gp. 784-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/all.12620 _zAvailable from publisher's website |
| 999 |
_c24764788 _d24764788 |
||